THE BASIC PRINCIPLES OF GGTI298 TRIFLUOROACETATE

quinupristin/dalfopristin will boost the level or outcome of avanafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. CYP3A4 inhibitors may cut down avanafil clearance expanding systemic exposure to avanafil; amplified concentrations may well end in amplified involved adverse gatherings; the utmost recommended dose of